PROTECTION OF XENOGENEIC CARDIAC ENDOTHELIUM FROM HUMAN-COMPLEMENT BY EXPRESSION OF CD59 OR DAF IN TRANSGENIC MICE

被引:31
作者
BYRNE, GW [1 ]
MCCURRY, KR [1 ]
KAGAN, D [1 ]
QUINN, C [1 ]
MARTIN, MJ [1 ]
PLATT, JL [1 ]
LOGAN, JS [1 ]
机构
[1] DUKE UNIV,MED CTR,DEPT SURG,DURHAM,NC 27710
关键词
D O I
10.1097/00007890-199511270-00016
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We investigated the ability of membrane-bound human complement regulatory proteins to control complement-driven humoral immune reactions on murine microvasculature. The human complement regulatory proteins CD59 and DAF were expressed using heterologous promoters in a variety of tissues in transgenic mice. Animals expressing these gene products are healthy and exhibit significant levels of endothelial cell expression of CD59 and DAF in cardiac muscle. Transgenic hearts perfused with human plasma exhibited profound reductions in the level of complement deposition compared with nontransgenic controls. We have also produced transgenic pigs that express these two human genes. Our results indicate that expression of complement regulatory proteins can control activation of complement and suggest that these proteins may have therapeutic applications in some inflammatory diseases and in the development of xenogeneic organs for human transplantation.
引用
收藏
页码:1149 / 1156
页数:8
相关论文
共 40 条
[1]  
ATKINSON J P, 1991, Clinical and Experimental Immunology, V86, P27
[2]   CRANIOFACIAL ABNORMALITIES INDUCED BY ECTOPIC EXPRESSION OF THE HOMEOBOX GENE HOX-1.1 IN TRANSGENIC MICE [J].
BALLING, R ;
MUTTER, G ;
GRUSS, P ;
KESSEL, M .
CELL, 1989, 58 (02) :337-347
[3]   IDENTIFICATION OF CIS SEQUENCES CONTROLLING EFFICIENT POSITION-INDEPENDENT TISSUE-SPECIFIC EXPRESSION OF HUMAN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-I GENES IN TRANSGENIC MICE [J].
CHAMBERLAIN, JW ;
VASAVADA, HA ;
GANGULY, S ;
WEISSMAN, SM .
MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (07) :3564-3572
[4]   ISOLATION AND CHARACTERIZATION OF 6 DIFFERENT CHICKEN ACTIN GENES [J].
CHANG, KS ;
ZIMMER, WE ;
BERGSMA, DJ ;
DODGSON, JB ;
SCHWARTZ, RJ .
MOLECULAR AND CELLULAR BIOLOGY, 1984, 4 (11) :2498-2508
[5]  
DALMASSO AP, 1992, AM J PATHOL, V140, P1157
[6]   INHIBITION OF COMPLEMENT-MEDIATED ENDOTHELIAL-CELL CYTOTOXICITY BY DECAY-ACCELERATING FACTOR - POTENTIAL FOR PREVENTION OF XENOGRAFT HYPERACUTE REJECTION [J].
DALMASSO, AP ;
VERCELLOTTI, GM ;
PLATT, JL ;
BACH, FH .
TRANSPLANTATION, 1991, 52 (03) :530-533
[7]   CD59, AN LY-6-LIKE PROTEIN EXPRESSED IN HUMAN LYMPHOID-CELLS, REGULATES THE ACTION OF THE COMPLEMENT MEMBRANE ATTACK COMPLEX ON HOMOLOGOUS CELLS [J].
DAVIES, A ;
SIMMONS, DL ;
HALE, G ;
HARRISON, RA ;
TIGHE, H ;
LACHMANN, PJ ;
WALDMANN, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 170 (03) :637-654
[8]   NEOANTIGEN OF THE POLYMERIZED 9TH COMPONENT OF COMPLEMENT - CHARACTERIZATION OF A MONOCLONAL-ANTIBODY AND IMMUNOHISTOCHEMICAL LOCALIZATION IN RENAL-DISEASE [J].
FALK, RJ ;
DALMASSO, AP ;
KIM, Y ;
TSAI, CH ;
SCHEINMAN, JI ;
GEWURZ, H ;
MICHAEL, AF .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 72 (02) :560-573
[9]  
FERNANDEZ HN, 1987, J IMMUNOL, V120, P102
[10]   EXPRESSION OF A FUNCTIONAL HUMAN-COMPLEMENT INHIBITOR IN A TRANSGENIC PIG AS A MODEL FOR THE PREVENTION OF XENOGENEIC HYPERACUTE ORGAN REJECTION [J].
FODOR, WL ;
WILLIAMS, BL ;
MATIS, LA ;
MADRI, JA ;
ROLLINS, SA ;
KNIGHT, JW ;
VELANDER, W ;
SQUINTO, SP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (23) :11153-11157